🇺🇸 US Stock Screener ← Switch market ★ Elite Club ⚡ StockGenie AI

NRC Health NRC R2K

Healthcare · Health Information Services · United States
https://www.nrchealth.com

NRC Health provides analytics and insights to measure and improve patient and employee experience for healthcare organizations in the United States. The company offers market experience solutions, a subscription-based services for improved tracking of awareness, perception, and consistency of healthcare brands; assessment of differentiators; and segmentation tools to evaluate the needs, wants, and behaviors of communities through assessments. It also provides patient experience solutions, a cross-continuum multi-mode digital platform that collects and measures data to improve patient experience, engagement, and loyalty; employee experience solutions, which combines health care with technology comprising engagement, pulse, lifecycle, culture of safety, and magnet RN satisfaction; and consumer experience solution that offers online reputation solutions, community insights, and cross-journey listening through nGage. In addition, the company offers Huey, an AI engine built for Human Understanding that serves as a healthcare experience management companion; and governance solutions provided through national conferences, publications, advisory services, and an online portal for not-for-profit health system boards of directors, executives, and physician leadership. Further, it provides patient experience, service recovery, care transitions, employee engagement, reputation management, rounding, and brand loyalty. The company was formerly known as National Research Corporation and changed its name to NRC Health April 2026. The company was founded in 1981 and is headquartered in Lincoln, Nebraska.

READ MORE ›
$19.53
+49.54% 1Y

Market & Price

Market Cap
$440.14M
Current Price
$19.53
High / Low (52W)
$22.27 / $11.22
Beta
0.34

Valuation

Stock P/E
47.63
Industry PE
23.65
Forward P/E
16.84
PEG Ratio
1.32
Book Value
$0.60
Price to Book
32.60
P/S
3.17
EV/EBITDA
14.90
Dividend Yield
3.07%

Profitability & Returns

ROCE
23.01%
ROE
41.86%
ROA
12.21%
Profit Margin
6.52%
Op Margin
16.00%
EPS (Latest Qtr)
$0.14
EPS (TTM)
$0.41

Balance Sheet & Liquidity

Debt/Equity
5.78
Quick Ratio
0.36
Current Ratio
0.52
Debt
$78.03M
Total Assets
$134.88M
Current Assets
$20.21M
Working Capital
$-16.41M

Ownership

Promoter Holding
48.96%
Chg in Prom Hold
-
FII / Inst Holding
49.68%
Chg in FII Hold
-

Financial Snapshot

Enterprise Value
$515.63M
Total Revenue (TTM)
$138.64M
EBITDA
$34.60M
Free Cash Flow
$19.73M
Operating Cash Flow
$26.98M
Shares Outstanding
22.54M
Gross Margin
61.80%
Payout Ratio
143.59%

Growth (CAGR)

Revenue 5Y
-3.22%
Profit 5Y
-28.55%
Revenue (YoY)
3.70%
Earnings (YoY)
-44.00%

PROS

  • Strong return on equity of 41.9%.
  • Healthy ROCE of 23.0%.
  • Attractive dividend yield of 3.07%.
  • Generates positive free cash flow.
  • In a confirmed uptrend (50-DMA above 200-DMA).

CONS

  • Revenue declined at -3.2% CAGR over 5 years.
  • Earnings shrank at -28.5% CAGR over 5 years.

* The pros and cons are auto-generated from financial metrics.

Price Chart

Robinhood TradingView StockAnalysis

Fundamental Growth

Figures from the latest reported periods. CAGR is computed across the displayed window (quarterly CAGR is annualised assuming 4 quarters per year).

Peer comparison

Peer companies in the same sector (Healthcare).

#NameCMP $P/E Mkt CapDiv Yld % ROCE %ROE % Rev CAGR 5Y %Profit CAGR 5Y %
1 NRC NRC Health R2K 19.53 47.63 $440.14M 3.07% 23.01% 41.86% -3.22% -28.55%
2 LLY Eli Lilly and Company SPX 1,105.00 39.21 $985.37B 0.63% 38.44% 107.46% 31.69% 48.96%
3 JNJ Johnson & Johnson SPX 225.33 26.11 $542.42B 2.38% 23.13% 26.42% 5.60% 14.32%
4 UNH UnitedHealth Group Incorporated SPX 380.31 28.66 $345.38B 2.32% 9.60% 12.18% 11.35% -15.69%
5 MRK Merck & Co., Inc. SPX 118.72 33.44 $293.22B 2.86% 20.66% 18.94% 3.12% 7.93%
6 TMO Thermo Fisher Scientific Inc. SPX 492.51 27.11 $183.03B 0.38% 9.17% 13.52% -0.27% -1.19%
7 AMGN Amgen Inc. NDXSPX 336.79 23.42 $181.77B 2.99% 18.02% 101.32% 11.77% 5.58%
8 GILD Gilead Sciences, Inc. NDXSPX 134.43 18.29 $166.90B 2.44% 22.92% 43.36% 2.57% 22.83%
9 ISRG Intuitive Surgical, Inc. NDXSPXAI 424.64 51.53 $150.39B - 15.96% 17.23% 17.39% 29.26%
Ad space

Quarterly Results

Figures in USD.

Metric Jun 2013Sep 2013Mar 2014Jun 2014Sep 2014Mar 2015Jun 2015Sep 2015Mar 2016Jun 2016Sep 2016Mar 2017Jun 2017Sep 2017Mar 2018Jun 2018Sep 2018Mar 2019Jun 2019Sep 2019Mar 2020Jun 2020Sep 2020Mar 2021Jun 2021Sep 2021Mar 2022Jun 2022Sep 2022Mar 2023Jun 2023Sep 2023Mar 2024Jun 2024Sep 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Revenue -----------------31.48M31.41M32.47M33.86M31.17M33.48M35.46M36.42M37.77M38.44M37.29M37.69M36.47M36.16M37.95M35.31M35.02M35.82M33.55M34.04M34.61M35.19M34.80M
Cost of Revenue -----------------------------------13.06M12.97M12.40M13.94M13.65M
Gross Profit -----------------------------------20.49M21.06M22.20M21.26M21.16M
Operating Expenses -----------------------------------11.90M19.48M14.47M16.59M15.59M
Operating Income 5.53M6.03M8.40M6.32M7.16M5.83M6.36M6.55M8.01M7.02M7.34M9.98M8.45M7.12M8.96M7.76M9.17M10.70M10.15M10.22M11.19M9.28M12.02M12.02M12.24M13.14M11.70M11.50M11.11M9.02M9.37M9.96M8.76M8.87M7.98M8.60M1.59M7.74M4.67M5.57M
EBITDA -----------------------------------10.16M3.35M9.93M6.78M7.80M
Interest Expense -----------------------------------899.00K1.03M1.46M1.37M1.25M
Pretax Income -----------------------------------7.72M581.00K6.27M3.27M4.38M
Tax Provision -----------------------------------1.94M687.00K2.15M1.47M1.16M
Net Income 3.43M3.81M5.45M4.05M4.55M3.48M4.06M4.14M5.51M4.56M4.73M6.52M5.75M4.15M7.31M7.95M6.99M------------------5.79M-106.00K4.12M1.80M3.22M
Diluted EPS -----------------0.320.290.310.460.300.370.360.350.380.340.330.330.280.290.320.270.260.240.25-0.010.180.080.14

Profit & Loss (Annual)

Figures in USD.

Metric Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue --------117.56M119.69M127.98M133.28M-151.57M148.58M143.06M137.39M
Cost of Revenue -------------57.05M56.02M56.93M52.37M
Gross Profit -------------94.52M92.56M86.13M85.02M
Operating Expenses -------------47.98M52.52M50.93M62.43M
Operating Income 13.70M13.86M18.73M22.72M24.81M28.30M26.45M31.20M34.22M35.27M43.03M42.68M-46.54M40.05M35.19M22.59M
EBITDA -------------49.30M46.72M41.31M30.23M
Interest Expense -------------1.21M862.00K2.60M4.76M
Pretax Income -------------42.81M39.96M32.69M17.84M
Tax Provision -------------11.02M8.99M7.91M6.25M
Net Income 8.49M11.56M11.56M15.07M15.48M18.16M17.61M20.52M22.94M30.05M---31.80M30.97M24.78M11.60M
Diluted EPS 1.261.261.692.17------1.261.45-1.271.251.040.50

Compounded Sales Growth

5 Years:-3.22%
1 Year:3.70%

Compounded Profit Growth

5 Years:-28.55%
1 Year:-44.00%

Stock Price Performance

1 Year:+49.54%
6 Months:+10.32%
3 Months:+46.98%
1 Month:+18.08%

Balance Sheet (Annual)

Figures in USD.

Metric Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Total Assets --95.77M100.68M100.05M111.09M129.51M128.05M120.62M127.32M108.03M110.69M133.42M-130.46M122.44M132.54M134.88M
Current Assets --------------43.72M24.36M19.60M20.21M
Cash & Equivalents 1.11M2.51M3.52M8.08M8.29M22.09M40.04M42.15M33.02M34.73M12.99M13.52M34.69M-25.03M6.65M4.23M4.14M
Inventory ------------------
Receivables --------------14.46M12.38M11.05M11.11M
Total Liabilities --47.19M45.12M43.30M39.33M41.76M53.83M37.82M37.27M88.95M77.79M69.11M-58.43M73.48M101.25M120.89M
Current Liabilities --26.15M24.40M35.30M23.78M27.93M44.17M31.51M32.31M47.11M38.16M31.68M-33.42M36.20M35.86M36.62M
Long Term Debt -----8.07M5.74M3.34M857.00K-34.18M29.80M26.55M-17.69M29.47M57.90M75.02M
Total Debt --------------22.18M36.68M62.68M79.03M
Total Equity 38.60M44.17M48.58M55.55M56.74M71.75M87.75M74.22M82.81M90.04M19.08M32.89M64.31M-72.03M48.95M31.28M13.99M
Shares Outstanding --------------30.92M31.00M31.07M31.97M

Cash Flows (Annual)

Figures in USD.

Metric Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Operating Cash Flow 13.67M14.60M18.48M19.13M19.32M26.20M21.89M26.84M28.09M39.85M40.92M40.64M-36.27M38.11M34.62M26.45M
Investing Cash Flow -3.00M-16.98M-6.93M-2.35M-2.19M-5.72M-1.33M-3.75M-6.12M-5.97M-4.66M-3.72M--9.84M-15.78M-20.28M-10.71M
Financing Cash Flow -9.55M3.25M-6.89M-16.69M-2.82M-1.73M-16.87M-32.50M-21.12M-54.50M-36.35M-15.50M--55.58M-40.71M-16.76M-15.84M
Capital Expenditure -2.91M-1.54M-2.81M-2.35M-2.19M-2.49M-2.94M-3.97M-4.57M-5.97M-4.66M-3.98M--9.84M-15.78M-15.45M-10.71M
Free Cash Flow 10.76M13.06M15.67M16.78M17.13M23.70M18.95M22.87M23.52M33.88M36.26M36.65M-26.43M22.33M19.18M15.74M
Net Change in Cash --------------29.15M-18.37M-2.42M-94.00K
Share Buybacks 84.00K399.00K----1.67M-----4.14M27.62M19.10M30.95M20.18M

Ratios (Annual)

Figures in %.

Metric Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Gross Margin % -------------62.4%62.3%60.2%61.9%
Operating Margin % --------29.1%29.5%33.6%32.0%-30.7%27.0%24.6%16.4%
Net Margin % --------19.5%25.1%---21.0%20.8%17.3%8.4%
ROE % 19.2%23.8%20.8%26.6%21.6%20.7%23.7%24.8%25.5%157.5%---44.1%63.3%79.2%82.9%
ROCE % -19.9%24.6%35.1%28.4%27.9%31.5%35.0%36.0%57.9%59.3%41.9%-48.0%46.4%36.4%23.0%

Shareholding Pattern

Insiders
48.96%
Institutions
49.68%
Public Float
97.32%

Top Institutional Holders

#Holder% HeldSharesValue
1 Kayne Anderson Rudnick Investment Management LLC 11.70% 2.64M $51.49M
2 Morgan Stanley 4.45% 1.00M $19.57M
3 Blackrock Inc. 4.33% 975.86K $19.06M
4 Vanguard Capital Management LLC 2.94% 662.84K $12.95M
5 Dimensional Fund Advisors LP 2.17% 489.74K $9.56M
6 Geode Capital Management, LLC 1.75% 393.85K $7.69M
7 QV Investors Inc. 1.69% 381.31K $7.45M
8 Renaissance Technologies, LLC 1.51% 340.78K $6.66M
9 State Street Corporation 1.33% 300.75K $5.87M
10 Hotchkis & Wiley Capital Management, LLC 1.27% 286.84K $5.60M

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for NRC

No recent headlines available.

Explore More

📊 Healthcare Sector 🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All USA Stocks